{"id":"https://openalex.org/W4254522015","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.752","title":"Baseline and early change of neutrophil to lymphocyte ratio (bNLR and \u0394NLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: Preliminary results of the Meet-URO 15 (I-BIO-REC) study.","display_name":"Baseline and early change of neutrophil to lymphocyte ratio (bNLR and \u0394NLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: Preliminary results of the Meet-URO 15 (I-BIO-REC) study.","publication_year":2020,"publication_date":"2020-02-19","ids":{"openalex":"https://openalex.org/W4254522015","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.752"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.6_suppl.752","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.752","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.752","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050343624","display_name":"Sara Elena Rebuzzi","orcid":"https://orcid.org/0000-0003-0546-6304","observed_orcids":["https://orcid.org/0000-0003-0546-6304"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Elena Rebuzzi","raw_affiliation_strings":["Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013913173","display_name":"Sebastiano Buti","orcid":"https://orcid.org/0000-0003-0876-0226","observed_orcids":["https://orcid.org/0000-0003-0876-0226"]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sebastiano Buti","raw_affiliation_strings":["Medical Oncology Unit, University Hospital of Parma, Parma, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy;","institution_ids":["https://openalex.org/I124601658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029935476","display_name":"Luca Galli","orcid":"https://orcid.org/0000-0001-6008-0266","observed_orcids":["https://orcid.org/0000-0001-6008-0266"]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Galli","raw_affiliation_strings":["Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy;","institution_ids":["https://openalex.org/I4210165410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057926104","display_name":"Giuseppe Procopio","orcid":"https://orcid.org/0000-0002-2498-402X","observed_orcids":["https://orcid.org/0000-0002-2498-402X"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Procopio","raw_affiliation_strings":["Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071060598","display_name":"Ugo De Giorgi","orcid":"https://orcid.org/0000-0001-7520-2908","observed_orcids":["https://orcid.org/0000-0001-7520-2908"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ugo De Giorgi","raw_affiliation_strings":["Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041434581","display_name":"Cinzia Baldessari","orcid":"https://orcid.org/0000-0003-3051-8057","observed_orcids":["https://orcid.org/0000-0003-3051-8057"]},"institutions":[{"id":"https://openalex.org/I4210109058","display_name":"Azienda Ospedaliero-Universitaria di Modena","ror":"https://ror.org/01hmmsr16","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109058"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia Baldessari","raw_affiliation_strings":["Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Mondea, Modena, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Mondea, Modena, Italy;","institution_ids":["https://openalex.org/I4210109058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063795761","display_name":"Francesco Massari","orcid":"https://orcid.org/0000-0001-6476-6871","observed_orcids":["https://orcid.org/0000-0001-6476-6871"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Massari","raw_affiliation_strings":["Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy;","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091765229","display_name":"Daniele Santini","orcid":"https://orcid.org/0000-0002-9118-3337","observed_orcids":["https://orcid.org/0000-0002-9118-3337"]},"institutions":[{"id":"https://openalex.org/I155125353","display_name":"Universit\u00e0 Campus Bio-Medico","ror":"https://ror.org/04gqx4x78","country_code":"IT","type":"education","lineage":["https://openalex.org/I155125353"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Santini","raw_affiliation_strings":["Department of Medical Oncology, Campus Bio-Medico-University of Rome, Rome, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Campus Bio-Medico-University of Rome, Rome, Italy;","institution_ids":["https://openalex.org/I155125353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077883336","display_name":"Alessia Cavo","orcid":"https://orcid.org/0000-0003-2157-3740","observed_orcids":["https://orcid.org/0000-0003-2157-3740"]},"institutions":[{"id":"https://openalex.org/I4405265896","display_name":"Ospedale Villa Scassi","ror":"https://ror.org/00mk34t10","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405264730","https://openalex.org/I4405265896"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessia Cavo","raw_affiliation_strings":["Oncology Unit, Villa Scassi Hospital, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Unit, Villa Scassi Hospital, Genova, Italy;","institution_ids":["https://openalex.org/I4405265896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033351253","display_name":"Giuseppe Luigi Banna","orcid":"https://orcid.org/0000-0003-0764-3650","observed_orcids":["https://orcid.org/0000-0003-0764-3650"]},"institutions":[{"id":"https://openalex.org/I4210135973","display_name":"Ospedale Cannizzaro","ror":"https://ror.org/03mtnpp42","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210135973"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Luigi Banna","raw_affiliation_strings":["Cannizzaro Hospital, Catania, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cannizzaro Hospital, Catania, Italy;","institution_ids":["https://openalex.org/I4210135973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077284495","display_name":"Mariella Sorar\u00f9","orcid":"https://orcid.org/0000-0001-5198-7755","observed_orcids":["https://orcid.org/0000-0001-5198-7755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariella Soraru'","raw_affiliation_strings":["Oncology Unit, Camposampietro Hospital, Camposampiero (Padua), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Unit, Camposampietro Hospital, Camposampiero (Padua), Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060954139","display_name":"Alessio Cortellini","orcid":"https://orcid.org/0000-0002-1209-5735","observed_orcids":["https://orcid.org/0000-0002-1209-5735"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]},{"id":"https://openalex.org/I4210098685","display_name":"San Salvatore Hospital","ror":"https://ror.org/0112t7451","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210098685"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessio Cortellini","raw_affiliation_strings":["Medical Oncology, St Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L'aquila, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, St Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L'aquila, Italy;","institution_ids":["https://openalex.org/I26415053","https://openalex.org/I4210098685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101955480","display_name":"Marco Messina","orcid":"https://orcid.org/0009-0009-8408-8217","observed_orcids":["https://orcid.org/0009-0009-8408-8217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Messina","raw_affiliation_strings":["Unit of Medical Oncology, Istituto Fondazione G. Giglio, Palermo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Medical Oncology, Istituto Fondazione G. Giglio, Palermo, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043134225","display_name":"Valentino Martelli","orcid":"https://orcid.org/0000-0002-4541-5299","observed_orcids":["https://orcid.org/0000-0002-4541-5299"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valentino Martelli","raw_affiliation_strings":["Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007550747","display_name":"Alessandra Damassi","orcid":"https://orcid.org/0000-0001-5052-0870","observed_orcids":["https://orcid.org/0000-0001-5052-0870"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandra Damassi","raw_affiliation_strings":["Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino of Genova, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino of Genova, Genova, Italy;","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012508480","display_name":"Andrea Sbrana","orcid":"https://orcid.org/0000-0003-4460-5282","observed_orcids":["https://orcid.org/0000-0003-4460-5282"]},"institutions":[{"id":"https://openalex.org/I4210165410","display_name":"Azienda Ospedaliera Universitaria Pisana","ror":"https://ror.org/05xrcj819","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165410"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Sbrana","raw_affiliation_strings":["Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy;","institution_ids":["https://openalex.org/I4210165410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008445367","display_name":"Giulia Apollonio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Apollonio","raw_affiliation_strings":["Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107026949","display_name":"Chiara Casadei","orcid":"https://orcid.org/0000-0003-2467-749X","observed_orcids":["https://orcid.org/0000-0003-2467-749X","https://orcid.org/0009-0003-9013-516X"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Casadei","raw_affiliation_strings":["Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy;","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028388712","display_name":"Alessio Signori","orcid":"https://orcid.org/0000-0001-6289-9144","observed_orcids":["https://orcid.org/0000-0001-6289-9144"]},"institutions":[{"id":"https://openalex.org/I83816512","display_name":"University of Genoa","ror":"https://ror.org/0107c5v14","country_code":"IT","type":"education","lineage":["https://openalex.org/I83816512"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessio Signori","raw_affiliation_strings":["Department of Health Sciences, Section of Biostatistics, University of Genoa, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Sciences, Section of Biostatistics, University of Genoa, Genova, Italy;","institution_ids":["https://openalex.org/I83816512"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081355165","display_name":"Giuseppe Fornarini","orcid":"https://orcid.org/0000-0003-4754-6572","observed_orcids":["https://orcid.org/0000-0003-4754-6572"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Fornarini","raw_affiliation_strings":["Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit 1, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy;","institution_ids":["https://openalex.org/I4210146472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"6_suppl","first_page":"752","last_page":"752"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7039999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peripheral-blood-biomarkers","display_name":"peripheral blood biomarkers","score":0.6840000152587891},{"id":"https://openalex.org/keywords/imdc-risk-stratification","display_name":"IMDC risk stratification","score":0.6980000138282776},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5339999794960022},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6050000190734863},{"id":"https://openalex.org/keywords/pd-1-pd-l1","display_name":"PD-1/PD-L1","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9570191502571106},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8935614824295044},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6289536952972412},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6192331910133362},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5480570197105408},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5050833821296692},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.439423143863678},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4384707808494568},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43751391768455505},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4126792550086975},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.40850234031677246},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33747535943984985},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.330390602350235},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26735493540763855},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.22399407625198364},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2224692404270172},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.09451082348823547},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.6_suppl.752","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.752","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.752","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3008672674","https://openalex.org/W3008952789","https://openalex.org/W3029127361","https://openalex.org/W7131865251","https://openalex.org/W2782319564","https://openalex.org/W4296844629","https://openalex.org/W2968347041","https://openalex.org/W2783295481","https://openalex.org/W3088425673","https://openalex.org/W4281776961"],"abstract_inverted_index":{"752":[0],"Background:":[1],"Biomarkers":[2],"to":[3,9,11,51,73,108,240,294],"select":[4],"mRCC":[5,34,347],"patients":[6,35,112,348],"most":[7],"likely":[8],"benefit":[10],"immune-checkpoint":[12],"inhibitors":[13],"are":[14],"still":[15],"needed.":[16],"The":[17],"ongoing":[18],"retrospective":[19],"multicentre":[20],"Meet-URO":[21],"15":[22],"(I-BIO-REC)":[23],"study":[24,44,336],"evaluates":[25],"the":[26,43,59,69,80,313],"prognostic":[27,339],"role":[28,340],"of":[29,42,63,71,307,334,341],"peripheral":[30],"blood":[31,54],"cells":[32],"in":[33,144,147,151,160,192,247,346],"treated":[36,349],"with":[37,200,227,255,281,319,325,329,350],"nivolumab.":[38,64,351],"Methods:The":[39],"primary":[40],"endpoint":[41],"was":[45,56,66,127,142,190,245],"median":[46],"overall":[47],"survival":[48,168],"(mOS)":[49],"according":[50],"bNLR.":[52],"Complete":[53],"count":[55],"collected":[57],"at":[58,84],"first":[60],"four":[61],"cycles":[62],"NLR":[65,83,241,324],"defined":[67],"as":[68,91,115],"ratio":[70],"neutrophil":[72],"lymphocyte":[74],"(cutoff":[75],"=":[76,93,213,268,279],"3)":[77],"and":[78,87,102,120,133,149,155,163,166,173,180,187,215,270,299,309,321,323,343],"\u0394NLR":[79,244,250,295,318,345],"difference":[81],"between":[82,317],"2nd":[85,116],"cycle":[86],"bNLR":[88,101,189,195,342],"(median":[89],"used":[90],"cutoff":[92],"0.3).":[94],"Here":[95],"we":[96],"reported":[97],"preliminary":[98],"analyses":[99,301,333],"on":[100],"DNLR.":[103],"Results:":[104],"From":[105],"May":[106],"2016":[107],"January":[109],"2019":[110],"189":[111],"started":[113],"nivolumab":[114],"(62%),":[117],"3rd":[118,122],"(25%)":[119],">":[121],"(13%)":[123],"line.":[124],"Median":[125],"age":[126],"69":[128],"years,":[129],"67%":[130],"were":[131,158,170,185],"male":[132],"87%":[134],"had":[135],"clear":[136],"cell":[137],"histology.":[138],"Baseline":[139],"IMDC":[140,304],"group":[141],"favorable":[143],"26%,":[145],"intermediate":[146],"63%":[148],"poor":[150],"11%.":[152],"Lymph-nodes,":[153],"visceral":[154],"bone":[156],"metastases":[157],"present":[159],"55%,":[161],"92%":[162],"37%.":[164],"mOS":[165],"progression-free":[167],"(PFS)":[169],"30.5":[171],"months":[172],"9.5":[174],"months.":[175],"Overall":[176],"response":[177],"rate":[178,183],"(ORR)":[179],"disease":[181],"control":[182],"(DCR)":[184],"28%":[186],"57%.":[188],"available":[191,246],"162":[193],"patients:":[194,249],"<":[196,225,251],"3":[197],"(52%)":[198],"correlated":[199,254],"statistically":[201,256,314],"significant":[202,257,315],"longer":[203,258],"PFS":[204,259,320],"[11.5":[205],"vs":[206,218,231,237,261,285,291],"5.6":[207],"months;":[208,220,263],"HR":[209,221,264,275],"1.61":[210],"(1.09-2.39),":[211],"p":[212,224,267,278],"0.017]":[214],"OS":[216,271,322,326],"[NR":[217],"22.4":[219],"2.61":[222],"(1.53-4.46),":[223],"0.001],":[226],"similar":[228,282],"ORR":[229,283],"(32%":[230],"32%)":[232,286],"but":[233,287,327],"higher":[234,288],"DCR":[235,289],"(66%":[236],"55%)":[238],"compared":[239,293],"\u2265":[242,296],"3.":[243],"136":[248],"0.3":[252],"(50%)":[253],"[17.1":[260],"8.5":[262],"1.57":[265],"(1.02-2.43)":[266],"0.04]":[269],"[medians":[272],"not":[273,328],"reached;":[274],"1.91":[276],"(1.04-3.51)":[277],"0.038],":[280],"(39%":[284],"(73%":[290],"56%)":[292],"0.3.":[297],"Univariate":[298],"multivariate":[300],"adjusted":[302],"for":[303],"group,":[305],"line":[306],"therapy":[308],"metastatic":[310],"sites,":[311],"confirmed":[312],"correlation":[316],"PFS.":[330],"Conclusions:":[331],"Preliminary":[332],"our":[335],"showed":[337],"a":[338],"early":[344]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}